aTyr Pharma (LIFE) Tops Q4 EPS by 22c

aTyr Pharma (NASDAQ: LIFE) reported Q4 EPS of ($0.26), $0.22 better than the analyst estimate of ($0.48). Revenue for the quarter came in at $10.4 thousand versus the consensus estimate of $416.67 thousand.

For earnings history and earnings-related data on aTyr Pharma (LIFE) click here.

You May Also Be Interested In

• Raymond James Downgrades Phreesia Inc. (PHR) to Market Perform
• After an 18% summer selloff in chip stocks, Citi asks what comes next
• Citi upgrades C.H. Robinson to Buy with $185 target, Opens 90-Day upside catalyst watch